FDA approves J&J sedation drug device

Fri May 3, 2013 9:06pm EDT

Related Topics

(Reuters) - U.S. regulators have approved Johnson & Johnson's Sedasys system to sedate patients during colonoscopies without the need for a physician to monitor delivery of the injectable sedating agent, the company said on Friday.

The device injects the patients who have different types of colonoscopy procedures with propofol, a minimal-to-moderate sedation agent widely used in colonoscopy procedures.

The system reduces the risks of oversedation when compared to other traditional methods, Johnson & Johnson said in a release, with 99 percent of patients recovering from the effects within 10 minutes after administration of the drug.

J&J said the system is expected to be introduced on a limited basis beginning in 2014.

The company estimates that 15 million patients in the United States are candidates for these procedures.

(Reporting by Ankur Banerjee and Adithya Venkatesan in Bangalore; Editing by Eric Beech)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.